Other languages Azenta, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 10:23:12 2024-06-18 EDT			5-day change	1st Jan Change
54.16 ^USD	-0.23%		-1.69%	-17.07%

06-05	Transcript : Azenta, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 11:00 AM
06-04	Azenta Picked to Support Crohn's Disease, Ulcerative Colitis Clinical Research	MT

Azenta, Inc. Announces Collaboration with the Crohn's & Colitis Foundation to Support Its Crohn's Disease and Ulcerative Colitis Clinical Research	06-04
Azenta Swings to Fiscal Q2 Adjusted Profit, Revenue Increases; 2024 Guidance Updated; Chief Executive Schwartz to Retire	05-09
Azenta, Inc. Provides Earnings Guidance for the Full Fiscal Year 2024	05-08
Stephen Schwartz to Retire as CEO of Azenta, Inc	05-08
Stephen Schwartz to Retire as Board Director of Azenta, Inc	05-08
Azenta, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-08
Azenta Seeks Tuck-In M&A	03-19
Nvidia's dizzying rally spurs rush into AI-themed ETFs	03-19
Azenta's Fiscal Q1 Non-GAAP Earnings, Revenue Decline	02-08
Azenta, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	02-07
Azenta, Inc. Announces the Launch of the BioArc Ultra	02-02
Azenta, Inc. Announces Election of Directors	02-01
Azenta, Inc. Provides Earnings Guidance for the Fiscal Year 2024	01-18
Ellen M. Zane Decides Not to Stand for Election to the Board of Directors of Azenta, Inc	01-17
Sector Update: Health Care Stocks Higher Late Afternoon	11-14
Sector Update: Health Care Stocks Advancing in Afternoon Trading	11-14
Azenta Shares Jump After Fiscal Q4 Beat	11-14
Azenta makes board changes, takes other steps; avoids proxy fight with activist	11-13
Azenta Fiscal Q4 Earnings Down, Revenue Up; Nominates New Members to Board	11-13
Azenta Seeks Acquisitions	11-13

No results for this search